COMMUNIQUÉS West-GlobeNewswire

Standard BioTools Reports Second Quarter 2025 Financial Results
11/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the second quarter ended June 30, 2025. [...]
Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
11/08/2025
FDA accepts NDA submission for Anaphylm™; PDUFA date set for January 31, 2026 Planning continues for a Q1 2026 U.S. launch of Anaphylm, if approved by the FDA Company accelerates Anaphylm global expansion strategy to [...]
Olema Oncology Reports Second Quarter 2025 Financial and Operating Results
11/08/2025
Selected 90 mg once-daily palazestrant for Part 2 of the OPERA-01 Phase 3 monotherapy trial and for the OPERA-02 Phase 3 trial in combination with ribociclib OPERA-01 enrollment ongoing with top-line data expected in [...]
Inventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference
11/08/2025
Daix (France), New York City (New York, United States), August 11, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development [...]
Inventiva Participera à la « Canaccord Genuity 45th Annual Growth Conference »
11/08/2025
Daix (France), New York City (New York, Etats-Unis), le 11 aout 2025 – Inventiva (Euronext Paris et Nasdaq : IVA ) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion
11/08/2025
WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN ), reiterates investor confidence and estimated asset value over $10 billion. In October 2024, HMP [...]
Booking Health Unveils New Study: Role of Immunotherapy in Extending Life Expectancy for Stage4 Cervical Cancer Patients
11/08/2025
Langenfeld, Germany, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Booking Health , a global leader in medical treatment coordination, today unveiled a new study titled Role of Immunotherapy in Extending Life Expectancy for Stage 4 [...]
REPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion
11/08/2025
Treatment of a subgroup of patients with post-acute sequelae of SARS-CoV-2. Forecast adds to Tevogen Bio's Oncology therapeutic area projections of $1 billion in the launch year and $10–$14 billion over the first five [...]
Esteworld Opens First UK Representative Office in London’s Covent Garden
11/08/2025
Photo: Esteworld Opens Its First Representative Office in the UK in London LONDON, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Turkish aesthetic healthcare group Esteworld has strengthened its presence in the UK market with the [...]
BHIANT Quarterly Update: North Texas Bio Innovation Gains Momentum with Workforce Development and Industry Collaboration
11/08/2025
DALLAS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- BHIANT , the workforce development arm of BioNTX, is charting new ground in biotechnology talent development and industry collaboration, strengthening North Texas’ position as a [...]
Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
11/08/2025
Total eligible patients in the US exceed 2 million. Treatment of SARS-CoV-2 infection in solid and hematologic cancer patients under active treatment. Reflects business philosophy of commercial success through patient [...]
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2025 Financial Results on August 14, 2025
11/08/2025
FREDERICK, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report [...]
NTG Nordic Transport Group publishes interim report for H1 2025
11/08/2025
Company announcement no. 9 – 25 11 August 2025 NTG Nordic Transport Group publishes interim report for H1 2025 The interim report for H1 2025 is enclosed. In connection with publication of the results for H1 2025, a [...]
Rising Cyber Threats to Brazil’s Health Sector Highlighted in New Health-ISAC Report
11/08/2025
Attacks on Brazil’s health system are rising, and limited intelligence sharing is contributing to put patient data and critical infrastructure at risk. ORLANDO, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Health-ISAC, a non [...]
Managed Healthcare Executive® announces 2025 PBMI Innovators Award winners
11/08/2025
Celebrating six visionaries driving meaningful innovation in pharmacy benefit management CRANBURY, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Managed Healthcare Executive® is proud to announce the winners of the 2025 PBMI [...]
TOMI Environmental Solutions Secures Order from ARES Distribution
11/08/2025
FREDERICK, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced that it has [...]
REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
11/08/2025
WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a [...]
PharmaTher Announces FDA Approval of Ketamine (KETARx™)
11/08/2025
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of [...]
BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results
11/08/2025
SUNNYVALE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported [...]

Pages